NOVOZYMES ADENIUM BIOTECH AS has a total of 120 patent applications. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), Australia and Israel. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are CARMOT THERAPEUTICS INC, AMGEN K A INC and WIESER RAIMUND J.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 18 | |
#2 | Australia | 15 | |
#3 | Israel | 9 | |
#4 | United States | 8 | |
#5 | WIPO (World Intellectual Property Organization) | 7 | |
#6 | African Regional Industrial Property Organization | 6 | |
#7 | Brazil | 6 | |
#8 | Canada | 6 | |
#9 | China | 6 | |
#10 | Mexico | 5 | |
#11 | New Zealand | 5 | |
#12 | South Africa | 5 | |
#13 | Argentina | 4 | |
#14 | Japan | 4 | |
#15 | Republic of Korea | 4 | |
#16 | Chile | 3 | |
#17 | Taiwan | 3 | |
#18 | Ukraine | 2 | |
#19 | Hungary | 1 | |
#20 | Philippines | 1 | |
#21 | Serbia | 1 | |
#22 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Basic materials chemistry | |
#5 | Environmental technology | |
#6 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Fodder | |
#5 | Soaps | |
#6 | Microorganisms | |
#7 | Foods | |
#8 | Preservation of human bodies | |
#9 | Climate change adaptation technologies | |
#10 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Mygind Per Holse | 51 |
#2 | Kruse Thomas | 38 |
#3 | Hoegenhaug Hans-Henrik Kristensen | 37 |
#4 | Brinch Karoline Sidelmann | 37 |
#5 | Kjaerulff Soeren | 36 |
#6 | Kjaer Tanja Maria Rosenkilde | 36 |
#7 | Andersen Birgitte | 32 |
#8 | Segura Dorotea Raventos | 26 |
#9 | Sandvang Dorthe | 13 |
#10 | Schoolnik Gary K | 9 |
Publication | Filing date | Title |
---|---|---|
AU2011203033A1 | Treatment of inflammatory bowel diseases with mammal beta defensins | |
UA99539C2 | Treatment of inflammatory bowel diseases with mammal beta defensins | |
KR20110031970A | Treatment of rheumatoid arthritis with mammal beta defensins | |
BRPI0909021A2 | use of a polypeptide, polypeptide, and method of treating meningitis | |
AU2009221324A1 | Use of defensins against tuberculosis | |
EP1863836A2 | Polypeptides having antimicrobial activity and polynucleotides encoding same | |
EP1861421A1 | Recombinant expression of insect defensins in Aspergillus | |
CN1980951A | Antimicrobial polypeptides | |
US2005124064A1 | Antimicrobial polypeptides from Pseudoplectania nigrella |